Engineered Nanoparticles for Prevention against CoVID-19 Infection

Abstract:

The sudden emergence of novel coronavirus CoVID-19 in China during the end of last year and its outburst all around the globe thereafter have raised serious questions about their instant management and diagnostic measures as it is infecting humans around in an exponential manner. The implementation of nanotechnology could perhaps ingenerate the rising distress due to the spread of the disease as the conventional antiviral drugs just control the symptoms. Nanoparticles drug delivery systems are engineered technologies that use nanoparticles for targeted drug delivery and controlled release of therapeutic agents. Nanoparticles based approach can replace the treatment with a more promising one that could meet these challenges. Understanding molecular pathogenesis of CoVID-19 infection is very important to exploit the nanoparticles to fight against it. A lot of nanostructures have been developed with antiviral and antibacterial properties for a variety of drug delivery and biomedical applications. The need of the hour is to exploit nano research to develop effective diagnostics tools, drugs, vaccines to treat and prohibit infection. In this paper an attempt has been made to understand the role and potential of various nanoparticles to inhibit CoVID-19 infection and its toxicity effects.

• Periodical: Advanced Materials Research (Volume 1166)
• Pages: 41-55
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.1166.41
• Online since: September 2021
• Authors: Raghav Dwivedi, Meetkamal Meetkamal*, Rajesh Kumar Dwivedi
• Keywords: CoVID-19, Drug Delivery, Nanoparticles, Toxicity

References

[1] M. K. Pervez and S. Parveen, Evolution and emergence of pathogenic viruses: Past, present and future,, Intervirology, 60 (2017) 1-7.

DOI: 10.1159/000478729

[2] I. V. Babkin and I. N. Babkina, The origin of the variola virus,, Viruses, 7 (2015) 1100-12.

DOI: 10.3390/v7031100

[3] N. H. De Jesus, Epidemics to eradication: the modern history of poliomyelitis,, Virology Journal, 4 (2007) 320-24.

[4] K. Subbarao, Advances in influenza virus research: A personal perspective,, Viruses 10 (12) (2018) 724.

DOI: 10.3390/v10120724

[5] E. Chlongitas and G. Ilonidis, Transmission of variecella-zoster virus originating from a patient with localized herpes zoster: Implications for infection control,, American J. Infection Controll., 38 (8) (2010) 669-670.

DOI: 10.1016/j.ajic.2010.02.010

[6] Y. L. Lau and J. S. M. Peiris, Pathogenesis of severe acute respiratory syndrome,, Curr. Opin. Immunol., 17 (2005) 404-410.

[7] T. A. Schawertz and A. S. Fauci, The extended impact of human immunodeficiency virus/AIDS Research,, J. Infect. Diseases, 219 (1) (2019) 6-9.

[8] S. L. Chen and T. R. Morgan, The natural history of hepatitis C virus (HCV) infection,, Int. J. Med. Sci. 3(2) (2006) 47-52.

[9] L. R. Stanberry, A. L. Cunningham, A. Mindal. L. L. Scott, S. L. Sparuance, F. Y. Aoki and C. L. Lacey, Prospects of control of herpes simplex virus disease through immunization,, Clinical Infectious diseases, 30 (3) (2000) 549-566.

DOI: 10.1086/313687

[10] A. H. Ropper, Acute Viral Encephalitis, N. Engl. J. Med., 379 (2018) 557-566.

[11] H. Mohd, J. Al-Tawfiq, Z. Memish, Middle east respiratory syndrome coronavirus (MERS-CoV): Origin and animal reservoir,, J. Virol. 13 (2016) 87-90.

DOI: 10.1186/s12985-016-0544-0

[12] A. H. Toosy, S. O'sullivan, An overview of middle east respiratory syndrome in the middle east", "Fowler Zoo and Wild Animal Medicine Current Therapy,, Volume 9 (2019) 287-291.

DOI: 10.1016/b978-0-323-55228-8.00042-4

[13] N. Satija and S. K. Lal, The Molecular biology of SARS coronavirus, Ann. N. Y. Acad. Sci. 1102 (2007) 26-38.

[14] T. M. Colpitts, M. J. Conway, R. R. Montgomery and E. Fikrig, West nile virus: Biology, transmission and human infection,, Clinical Microbiology reviews, 25 (4) (2012) 635-648.

DOI: 10.1128/cmr.00045-12

[15] A. M. McCollum and I. K. Damon, Human monkeypox,, Clinical Infectious Diseases, 58 (2), (2014) 260-267.

DOI: 10.1093/cid/cit703

[16] C. McCaughey and C. A. Hart, Hantaviruses,, J. Med. Microbiol, 49 (2000) 587-599.

[17] S. P. Luby, The pandemic potential of Nipah virus,, Antiviral Research, 100 (2013) 38-43.

DOI: 10.1016/j.antiviral.2013.07.011

[18] H. Field, P. Young, J. M. Yob, J. Mills, L. Hall and J. Mackenzie, The natural history of Hendra and Nipah viruses,, Microbes and Infection, 3 (2001) 307-14.

DOI: 10.1016/s1286-4579(01)01384-3

[19] O. Schwartz and M. L. Albert, Biology and pathogenesis of Chikungunya virus,, Nature Reviews Microbiology 8(7) (2010) 491-500.

DOI: 10.1038/nrmicro2368

[20] W. Y. Khot and M. Y. Nadkar, The 2019 novel coronavirus outbreak-A global threat,, J. of the Association of Physicians of India, 68 (2020) 67-72.

[21] D. K. Chu, Y. Pan, S. M. S. Cheng, K.P. Y. Hui, P. Krshnan, Y. Liu, D. Y. M. Ng, C. K. C. Wan, P. Yang, Q. Wang, M. Peiris and L. L. M. Poon, Molecular diagnosis of a novel coronavirus (2019-nCOV) causing an outbreak on pneumonia, Clinical Chemistry, 66 (4), (2020) 549-555.

DOI: 10.1093/clinchem/hvaa029

[22] H. Yang, M. Bartlam and Z. Rao, Drug design targeting the main protease, the Achilles' heel of coronaviruses,, Current Pharmaceutical Des. 12 (2006) 4573-90.

DOI: 10.2174/138161206779010369

[23] S. Belouzard, J. K. Millet, B. N. Licitra and G. R. Whittaker. Mechanisms of coronavirus cell entry mediated by the viral spike protein,. Viruses, 4 (6) (2012) 1011-33.

DOI: 10.3390/v4061011

[24] X. Li, M. Geng, Y. Peng, L. Meng, S. Lu, Molecular immune pathogenesis and diagnosis in CoViD-19,, J. Pharm. Anal., 10 (2020) 102-108.

[25] M. A. Shereen and R. Siddique, CoVID-19 infection: Origin, transmission and characteristics of human coronavirus,, J. Adv. Res. 24 (2020) 91-98.

[26] A. W. H. Chin, J. T. S. Chu, M. R. A. Perera, K. P. Y. Hui, H. L. Yen, M. C. W. Chen, M. Peiris and L. L. M. Poon, Stability of SARS-CoV-2 in different environmental conditions,, The Lancet, 1(1) (2020) E10.

DOI: 10.1016/s2666-5247(20)30003-3

[27] B. Khodashenas and H. R. Ghorbani, Synthesis of silver nanoparticles with different shapes,, Arabian J. Chem. 12 (8) (2019) 1823-38.

DOI: 10.1016/j.arabjc.2014.12.014

[28] R. G. Kerry and S. Majhi, "Nano-based approach to combat emerging viral (NIPAH virus) infection, Nanotechnol., Biology and Medicine, 18 (2019) 196-220.

DOI: 10.1016/j.nano.2019.03.004

[29] M. C. Sportelli, M. Izzi, E. A. Kukushkina, S. I. Hossain, R. A. Picca, N. Ditaranto and N. Cioffi, Can Nanotechnology and materials science help to fight against SARS-CoV-2?,, Nanomaterials, 10 (2020) 802-15.

DOI: 10.3390/nano10040802

[30] M. Vincent, R. E. Duval, P. Hartemann and M. Engels-Deutsch, Contact killing and antimicrobial properties of copper,, J. Appl. Microbiology, 124 (5) (2017) 1032-46.

DOI: 10.1111/jam.13681

[31] J. K. Patra and K. H. Baek, Antibacterial activity and synergistic antiviral potential of biosynthesized silver nanoparticles against foodborne pathogenic bacteria alongwith its anticandidal and antioxidant effects,, Front. Microbiol. (2017) https://doi.org/10.3389/fmicb.2017.00167.

DOI: 10.3389/fmicb.2017.00167

[32] B. L. Ouay and F. Stellacci, Antibacterial activity of silver nanoparticles: A surface science insight, Nanotoday, 10 (3) (2015) 339-354.

DOI: 10.1016/j.nantod.2015.04.002

[33] L. Wang, C. Hu and L. Shao, The antimicrobial activity of nanoparticles: Present situation and prospects for the future,, I. J. Nanomedicine, 12 (2017) 1227-1249.

DOI: 10.2147/ijn.s121956

[34] O Zachar, Formulation of COVID-19 treatment via silver nanoparticles inhalation delivery,, www.scienceopen.com, 28 March (2020).

[35] S. Pal, Y. K. Tak, and J. M. Song, Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli,, Appl. Environ. Microbiol., 73 (2007) 1712–1720.

DOI: 10.1128/aem.02218-06

[36] I. Sondi and B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria,, J. Colloid Interface Sci., 275 (2004) 177–182.

DOI: 10.1016/j.jcis.2004.02.012

[37] J. R. Morones, J. L. Elechiguerra, A. Camacho, K. Holt, J. B. Kouri, J. T. Ramirez, and M. J. Yacaman, The bactericidal effect of silver nanoparticles,, Nanotechnology, 16 (2005) 2346–2353.

DOI: 10.1088/0957-4484/16/10/059

[38] M. Gajbhiye, J. Kesharwani, A. Ingle, A. Gade and M. Rai, Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole, Nanomedicine, 5 (2009) 382–386.

DOI: 10.1016/j.nano.2009.06.005

[39] S. Y. Liau, D. C. Read, W. J. Pugh, J. R. Furr and A. D. Russell, Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions,, Lett. Appl. Microbiol. 25 (1997) 279–283.

DOI: 10.1046/j.1472-765x.1997.00219.x

[40] M. Marini, N. De Niederhausern, R. Iseppi, M. Bondi, C. Sabia and M. Toselli, Antibacterial activity of plastics coated with silver-doped organic-inorganic hybrid coatings prepared by sol–gel processes,, Biomacromolecules 8 (2007) 1246–1254.

DOI: 10.1021/bm060721b

[41] J. Elechiguerra, J. L. Burt, J. R. Morones, A. Camacho-Bragado, X. Gao, H. H. Lara and M. Yacaman, Interaction of silver nanoparticles with HIV-1,, J. Nanobiotechnology, 3, (2005) 6.

DOI: 10.1186/1477-3155-3-6

[42] J. C. Trefry and D. P. Wooley, Rapid assessment of antiviral activity and cytotoxicity of silver nanoparticles using a novel application of the tetrazolium-based colorimetric assay, J. Virol. Methods, 183 (2012) 19–24.

DOI: 10.1016/j.jviromet.2012.03.014

[43] L. Lu, R. W. Sun, R. Chen, C. K. Hui, C. M. Ho, J. M. Luk, G. K. Lau and C. M. Che, Silver nanoparticles inhibit hepatitis B virus replication, Antivir. Ther. 13 (2008) 253–262.

DOI: 10.1177/135965350801300210

[44] D. Baram-Pinto, S. Shukla, N. Perkas, A. Gedanken and R. Sarid, Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate,, Bioconjugate Chem. 20 (2009) 1497–1502.

DOI: 10.1021/bc900215b

[45] L. Sun, A. K. Singh, K. Vig, S. R. Pillai and S. R. Singh, Silver nanoparticles inhibit replication of respiratory syncytial virus,, J. Biomed. Nanotechnol., 4 (2008) 149–158.

DOI: 10.1166/jbn.2008.012

[46] J. V. Rogers, C. V. Parkinson, Y. W. Choi, J. L. Speshock and S. M. Hussain, A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation,, Nanoscale Res. Lett., 3 (2008) 129–133.

DOI: 10.1007/s11671-008-9128-2

[47] J. L. Speshock, R. C. Murdock, L. K. Braydich-Stolle, A. M. Schrand and S. M. Hussain, Interaction of silver nanoparticles with Tacaribe virus,, J. Nanobiotechnology, 8 (2010) 19.

DOI: 10.1186/1477-3155-8-19

[48] P. Mehrbod, N. Motamed, M. Tabatabaian, E. R. Soleimani, E. Amini, M. Shahidi and M. T. Kheiri, In vitro antiviral effect of "nanosilver" on influenza virus, J. Pharm. Sci., 17 (2009) 88–93.

[49] D. X. Xiang, Q. Chen, L. Pang and C. L. Zheng, Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro, J. Virol. Methods, 178 (2011) 137–142.

DOI: 10.1016/j.jviromet.2011.09.003

[50] A. Kumar, P. K. Vemual and G. John, Silver-nanoparticle-embedded antimicrobial pain based on vegetable oil,, Nature materials, 7 (2008) 236-241.

DOI: 10.1038/nmat2099

[51] S. Arora, J. Jain, J. M. Rajwade and K. M. Paknikar, Cellular responses induced by silver nanoparticles: In vitro studies, Toxicol Lett. 179 (2008) 93-100.

DOI: 10.1016/j.toxlet.2008.04.009

[52] L. Dykman and N. Khlebtsov, Gold nanoparticles in biomedical applications: Recent advances and perspectives,, Chem. Soc. Rev. 41 (2012) 2256-82.

DOI: 10.1039/c1cs15166e

[53] L. A. Dykman and N. G. Khlebtsov, Immunological properties of gold nanoparticles,, Chem. Sci. 8 (2017) 1719-1735.

DOI: 10.1039/c6sc03631g

[54] M. A. K. Abdelhalim, M. Ghannam, M. M. Mady, Physical properties of different gold nanoparticles: UV-visible fluorescence measurements,, J. Nanomed. & Nanotechol. 3 (3) (2012),.

[55] S. Jain, D. G. Hirst and J. M. O'Sullivan, Gold nanoparticles a novel agents for cancer therapy,, British J. Radiology, 85 (1010) (2012) 101-113.

DOI: 10.1259/bjr/59448833

[56] V. Amendola, R. Pilot, M. Frasconi, O. M. Marago and M. Antonia Lati, Surface Plasmon Resonance in gold nanoparticles: A review,, J. Phys. Condens. Matter, 29 (10) (2017).

DOI: 10.1088/1361-648x/aa60f3

[57] S. Karime, A. Moshalli and M. Nikkalah, Surface plasmon resonance in small gold nanoparticles: Introducing a size-dependent plasma frequency for nanoparticles in quantum regime,, Plasmonics, 14 (2019) 851-860.

DOI: 10.1007/s11468-018-0866-4

[58] J. C. Y. Kah, K. W. Kho, C. G. L. Lee, C. James, R. Sheppard, Z. X. Shen, K. C. Soo and M. C. Olivo, Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles,, Int. J. Nanomedicine, 2(4) (2007) 785-98.

[59] A. Wozniak, Anna Mlankowska and S. Jurga, Size and shape dependent cytotoxity profile of gold nanoparticles for biomedical applications,, J. Materials Science: Materials in medicine, 28 (2017), 850-56.

[60] X. Xie, J. Liao, Q. Li and Y. Lin, The effect of shape on cellular uptake of gold nanoparticles in the forms of stars, rods and triangle,, Scientific report, 7 (2017).

DOI: 10.1038/s41598-017-04229-z

[61] J. Jeong, E. Choi. E. Ellis and T. C. Lee, Recent advances in gold nanoparticles for biomedical applications: from hybrid structures to multi-functionality,, J. Materials Chem. B, 22 (2019).

DOI: 10.1039/c9tb00557a

[62] L. Wang, W. Ma, L. Xu, W. Chen, Y. Zhu, C. Xu and N. A. Kotov, Nanoparticle-based environmental sensors, Mater. Sci. Eng. Res. R70 (2010), 265 – 274.

[63] S. Yi, L. Sun, S. C. Lenaghan, Y. Wang, X. Chong, Z. Zhang and M. Zhang, "One-step synthesis of dendritic gold nanoflowers with high surface-enhanced Raman scattering (SERS) properties, RSC Advances 3 (2013), 10139.

DOI: 10.1039/c3ra40716k

[64] C. L. Nehl, H. Liao and J. H. Hafner, Optical properties of star-shaped gold nanoparticles,, Nano Lett. 6 (2006), 683-88.

DOI: 10.1021/nl052409y

[65] Y. Ji, M. Ren, Y. Li, Z. Huang, M. Shu, H. Yang, Y. Xiong and Y. Xu, Detection of aflatoxin B1 with immunochomatographic test strips: Enhanced signal sensitivity using gold nanoflowers,, Talanta 142 (2015) 206-212.

DOI: 10.1016/j.talanta.2015.04.048

[66] D. O'Neal, L. R. Hirsch, N. J. Halas, J. D. Payne and J. L. West, Photothermal tumor ablation in mice using near infrared absorbing nanoparticles,, Cancer Lett. 209 (2) (2004) 171-176.

DOI: 10.1016/j.canlet.2004.02.004

[67] Z. K. Alghrair, D. G. Fenig and B. Ebrahimi, Enhanced inhibition of influenza virus infection by peptide-noble-metal nanoparticles conjugates,, Beilstein J. Nanotechnol., 10 (2019) 1038-47.

DOI: 10.3762/bjnano.10.104

[68] A. M. Paul, Y. Shi, D. Acharya, J. R. Douglas, A. Cooleye, J. F. Anderson, F. Huang and F. Bai, Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro,, J. of General Virology, 95 (8) (2014) 1712-22.

DOI: 10.1099/vir.0.066084-0

[69] ScienceDaily, 18 April 2017, Using nanoparticles to detect deadly viruses,, www.sciencedaily.com/releases/2017/170418115534.htm.

[70] A. K. Khan, R. Rashid, G. Murtaza and A. Zahra, Gold nanoparticles: synthesis and applications in drug delivery,, Tropical J. Pharmaceutical Res., 13 (7) (2014) 1169-77.

DOI: 10.4314/tjpr.v13i7.23

[71] G. M. Ziarani, M. Malmir, N. Lashgari and A. Badiei, The role of magnetic nanoparticles in drug delivery,, RSC Advances, 43 (2019) 25094-106.

DOI: 10.1039/c9ra01589b

[72] C. Rumenapp and B. Gleich, Magnetic nanoparticles in magnetic resonance imaging and diagnostics,, Pharmaceutical Res., 29 (5) (2012) 1165-79.

DOI: 10.1007/s11095-012-0711-y

[73] H. Fatima and K. Kim, Magnetic particles for bioseperation,, K. J. Chem. Engin., 34 (3) (2017) 589-599.

[74] C. A. Hermann, C. Hofmann, A. Duuerkop and A. J. Baeumner, Magnetosomes for bioassays by merging fluorescent liposomes and magnetic nanoparticles: encapsulation and bilayer insertion strategies,, Analytical and Bioanalytical Chemistry, (2020) doi.org/10.1007/s00216-020-02503-0.

DOI: 10.1007/s00216-020-02503-0

[75] M. N. Zharkov, M. V. Gerasimov, D. B. Trushina, D. N. Khmelenin, E. V. Gromova, D. E. Yakobson and M. A. Pyataev, Two types of magnetite-containing liposomes for magnetic controlled drug release,, J. Phys.: Conference series, 1389 (2019).

DOI: 10.1088/1742-6596/1389/1/012070

[76] S. D. Anderson, V. V. Gwenin and C. D. Gwenin, Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications,, Nanoscale Res. Lett. 14 (2019), doi.org/10.1186/s11671-019-3019-6.

DOI: 10.1186/s11671-019-3019-6

[77] M. Yallapu, S. Foy, T. K. Jain and V. Labhasetwar, PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications,, Pharma. Res. 27 (11) (2010) 2283-95.

DOI: 10.1007/s11095-010-0260-1

[78] N. Jhu, H. Ji, P. Yu, J. Niu, M. U. Farooq, M. W. Akram, I. O. Udego, H. Li and X. Niu, Surface modifications of magnetic iron oxide nanoparticles,, Nanomaterials 8 (2018) 810-837.

DOI: 10.3390/nano8100810

[79] M. T. Muneer, M. A. A. Shah and S. Umar, "Potential of magnetic nanoparticles for Hepatitis B virus detection, J. Nanoscin. & Nanotechnol. 16 (2016) 12112-123.

[80] N. Panwar, A. M. Soehartono, K. K. Chan, S. Zeng, G. Xu, P. Coquet, K. T. Yong and X. Chen, Nanocarbons for biology and medicine: Sensing, imaging and drug delivery,, Chem. Rev. 119 (2019) 9559-9656.

DOI: 10.1021/acs.chemrev.9b00099

[81] E. Bekayarova, Y. Ni, E. B. Malarkey, V. Montana, J. C. McWillams, R. C. Haddon and V. Parpura, Applications of carbon nanotubes in biotechnology and biomedicines,, J. Biomed. Nanotechnol. 1(1) (2005) 3-17.

[82] W. Zhang, Z. Zhang and Y. Zhang, The application of carbon nanotubes in target drug delivery system for cancer therapies,, Nanoscale Research Lett. 6 (2011) 555-577.

DOI: 10.1186/1556-276x-6-555

[83] B. Esmaeil, N. S. Masoumeh, H. K. Saeed, Y. Meysam, B. Armin, K. Erfan, S. Monajemi aand K. Mahshad, Carbon nanostructures: The current potential applications in tissue Engineering,, J. Tissue Eng. (2019) 21-41.

[84] L. Tang, Y. Wang, Y. Liu and J. Li, DNA-directed self assembly of graphene oxide with applications to ultrasensitive oligonucleotide assay,, ACS Nano 5 (5) (2011) 3817-22.

DOI: 10.1021/nn200147n

[85] J. Ping, R. Visnubhotla, A. Vrudhula and A. T. Charlie Johnson, Scalable production of high sensitivity, level free DNA biosensors based on back gated field effect transistors,, ACS Nano, 10 (2016) 8700-04.

DOI: 10.1021/acsnano.6b04110

[86] P. Innocenzi and L. Stagi, Carbon-based antiviral nanomaterials: graphene, C-dots and fullerenes. A perspective,, Chemical Science 11 (2020) 6606-22.

DOI: 10.1039/d0sc02658a

[87] P. I. Anderson, A. Ianevski, H. Lysvand, A. Vitkauskiene, V. Oksenych, M. Bjoras, K. Telling, I. Lutsar, U. Dumpis, Y. Irie, T. Tenson, A. Kantele and D. E. Kainov, Discovery and development of safe-in-man broad-spectrum antiviral agents,, I. J. Infectious Diseases, 93 (2020) 268-276.

DOI: 10.20944/preprints201910.0144.v4

[88] T. Du, J. Liang, N. Dong, J. Lu, Y. Fu, L. Fang, S. Xiao and H. Han, Glutathione-capped Ag2S nanoclusters inhibit coronavirus proliferation through blockage of viral RNA synthesis and budding,, ACS Appl. Mater. Interfaces 10 (2018) 4369-78.

DOI: 10.1021/acsami.7b13811

[89] Y. N. Chen, Y. H. Hsueh, C. T. Hseih, D. Y. Tzou and P. L. Chang, Antiviral activity of graphene-silver nanocomposites against non-enveloped and enveloped viruses,, Int. J. Environ. Res. Public Health 13 (4) (2016) 430-36.

DOI: 10.3390/ijerph13040430

[90] L. A. Laygah and S. Eissa, An electrochemical immunosensor for corona virus associated with the middle east respiratory syndrome using an array of gold nanoparticles-modified carbon electrodes,, Microchimca Acta, 186 (2019), doi.org/10.1007/s00604-019-3345-5.

DOI: 10.1007/s00604-019-3345-5

[91] S. Kang, W. Peng, Y. Zhu, S. Lu, M. Xhou, W. Lin, W. Wu, S. Huang, L. Jiang, X. Luo and M. Deng, Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detention, mechanisms and treatment,, Int. J. Antimicrobial Agents, 55 (2020) 105950.

DOI: 10.1016/j.ijantimicag.2020.105950

[92] M. S. Draz and H. Shafiee, Applications of gold nanoparticles in virus detection,, Theranostics 8 (2018) 1985-2017.

DOI: 10.7150/thno.23856

[93] J. Kang, A. Tahir, H. Wang and J. Chang, Applications of nanotechnology in virus detection, tracking and infection mechanisms,, WIREs Nanomed Nanobiotechnol. (2021) e1700.

DOI: 10.1002/wnan.1700

[94] Z. Li, Y. Yi, X. Luo, N. Xiong, Y. Liu, S. Li, R. Sun, Y. Wang, B. Hu, W. Chen, Y. Zhang, J. Wang, B. Huang, Y. Lin, J. Yang, W. Cai, X. Wang, J. Cheng, Z. Chen, K. sun, W. Pan, Z. Zhan, L. Chen and F. Ye, Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnostics,, J. Medical Virology, 92 (2020) 1518-24.

DOI: 10.1002/jmv.25727

[95] B. Alhalaili, I. N. Popescu, O. Kamoun, F. Alzubi, S. Alawadhia and R. Vidu, Nanobiosensors for the detection of novel coronavirus 2019-nCoV and other pandemic/Epidemic respiratory viruses: a review,, Sensors 20 (2020) 6951.

DOI: 10.3390/s20226591

[96] M. Turner, V. B. Golovko, O. P. H. Vaughan, P. Abdulkin, A. Berenguer-Murcia, M. S. Tikhov, B. F. G. Johnson and R. M. Lambert, Selective oxidation with dioxygen by gold nanoparticles derived from 55-atom clusters,, Nature, (2008) 981-985;.

DOI: 10.1038/nature07194

[97] A. M. Alkilany and C. J. Murphy, Toxicity and cellular uptake of gold nanoparticles: what we have learned so for,, J. Nanopart. Res. 12 (7) (2010) 2313-33.

DOI: 10.1007/s11051-010-9911-8

[98] L. Mohammed, D. Ragab and H. Gomaa, Bioactivity of hybrid polymeric magnetic particles and their applications in drug delivery,, Current Pharm. Des., 22 (22) (2016) 3332-52.

DOI: 10.2174/1381612822666160208143237

[99] R. V. Ghartavol, A. A. M. Borojeni, Z. V. Ghatavoi, H. T. Aiyelabegan and M. R. Jaafari, Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues,, Artificial cells, Nanomedicine and biotechnology, 48 (2020).

DOI: 10.1080/21691401.2019.1709855

[100] J. Muller, F. Huaux, N. Moreau, P. Misson, J. F. Heilier, M. Delos, M. Arras, A. Fonseca, J. B. Nagy and D. Lison, Respiratory toxicity of multiwall carbon nanotubes,, Toxicology and Appl. Pharmacology, 207 (2005) 221-231.

DOI: 10.1016/j.taap.2005.01.008

[101] S. Kumar and S. H. Parekh, Linking graphene-based material physicochemical properties with molecular adsorption, structure and cell fate,, Communications Chemistry, 3 (2020).

DOI: 10.1038/s42004-019-0254-9

[102] Y. Chong, C. Ge, Z. Yang, J. A. Garate, Z. Gu, J. K. Weber, J. Liu and R. Zhou, Reduced cytotoxicity of graphene nanosheets mediated by blood protein coating,, ACS Nano, 9 (6), (2015) 5713-24.

DOI: 10.1021/nn5066606